The Company undertakes no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law. ChromaDex Investor Contact: The Del Mar Consulting Group, Inc. Robert B. Prag, President 858-794-9500 or Alex Partners, LLC Scott Wilfong, President 425- 242-0891 ChromaDex Company Contact: Laura Carney, Executive Assistant 949-419-0288 Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease. SOURCE ChromaDex / Beckerman PR